Articles related to VALUE-BASED CARE

HRSA’s revised 340B rebate pilot could require covered entities to purchase selected high-cost drugs at full price and recover discounts through manufacturer rebates beginning in 2027, prompting hospitals to evaluate data infrastructure, vendor readiness, and reimbursement workflows while legal and congressional challenges continue.

Across 14 health-system specialty pharmacies, pharmacist interventions were associated with an estimated $3.6 million in avoided medication costs over six months. The analysis used a structured attribution method to assess the likelihood that individual interventions altered treatment trajectories.

Patients receiving telehealth visits had statistically higher rates of emergency department use (38.2% vs 30.2%) and inpatient stays (29.9% vs 21.6%) than patients exclusively seen and examined by their physicians in person.

In light of recent disruptions, it’s crucial for healthcare systems to reconsider how consolidation impacts patient care and to explore diverse value-based care models that prioritize patient outcomes.

Embrace the future of healthcare with AI-driven value-based care models, designed to optimize patient outcomes while addressing the pressing challenge of rising healthcare costs.

Dr. Barbara L. McAneny’s withdrawal from the EOM program underscores the critical need for healthcare models to align with the realities of patient care, especially in community settings where the impact of social determinants is most pronounced.